Financial Reports and Presentations

2007

2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2006
2005
All years

Annual Reports

Interim Reports
Other
Presentations
All types

	Report	Presentation	Webcast

Investor contact

Cord Communications

IR@oasmia.com

+46 18-50 54 40

Subscribe to our news

Investors

About Us
Our Science
Corporate Governance
Investors
Media
Contact

Oasmia Pharmaceutical AB develops, manufactures, markets and sells an improved generation of drugs within human and veterinary oncology. Product development aims to produce novel formulations of well-established cytostatic agents which show improved performance, an improved side-effect profile and a wider range of therapeutic areas compared with existing alternatives. Product development is based on the proprietary technology platform XR-17.

The Share

Follow the share

Personal data
Cookies

OAS-MA-P-001-SEP2020

Oasmia Pharmaceutical AB
Vallongatan 1, 752 28
Uppsala, Sweden

Tel +46 18 50 54 40
Fax +46 18 51 08 73
info@oasmia.com